New antibiotic tested in fight against Drug-Resistant e. coli
NCT ID NCT07318584
Summary
This study is testing whether the antibiotic cefotetan works as well as standard antibiotics for hospitalized patients with serious E. coli infections in the blood or urinary tract. About 84 participants will be randomly assigned to receive either cefotetan or standard antibiotic treatment and followed for 30 days. The goal is to see if cefotetan can effectively treat these infections, including some that are resistant to other common antibiotics.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for E COLI INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.